wegovy glp-1 receptor agonist hydration effects 2025 GI Adverse of Glucagon-Like Peptide-1 Agonists Hydration on GLP-1s: Preventing Side

Semaglutide, among other antidiabetic drugs, has shown an association with cancer as it alters the rates of tumorigenesis and proliferation

Beiroa et al., 2014

The FDA looks for conclusive evidence that these drugs are both effective and safe at treating obesity in people, with or without diabetes

& Burne, T

In addition to NAION, Wegovy patients may also face temporary blurred vision from fluctuating blood sugar levels, an increase in eye infections, and other vision issues

Advertisement SELECT was designed to determine whether semaglutide can exert protective cardiovascular effects in patients with overweight or obesity in the absence of diabetes